Go Pro
→ The cat is out the bag (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$532.56
-0.9%		$487.27
$365.20
▼
$557.00
$6.96B0.51218,882 shs72,470 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$28.65
-0.4%		$32.07
$13.74
▼
$65.30
$6.63B2.426.51 million shs3.71 million shs
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.23
+2.2%		$24.70
$19.53
▼
$28.82
$2.84B0.85997,365 shs250,896 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$52.42
-3.5%		$51.68
$40.77
▼
$104.32
$9.45B3.585.77 million shs1.25 million shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-0.94%-2.30%+9.14%+23.47%+18.98%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-3.47%-2.86%-18.06%+14.88%-40.43%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
+1.02%-1.09%-22.37%-5.19%+3.52%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-0.59%+17.71%-7.47%+23.58%-22.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$532.56
-0.9%		$487.27
$365.20
▼
$557.00
$6.96B0.51218,882 shs72,470 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$28.65
-0.4%		$32.07
$13.74
▼
$65.30
$6.63B2.426.51 million shs3.71 million shs
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.23
+2.2%		$24.70
$19.53
▼
$28.82
$2.84B0.85997,365 shs250,896 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$52.42
-3.5%		$51.68
$40.77
▼
$104.32
$9.45B3.585.77 million shs1.25 million shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-0.94%-2.30%+9.14%+23.47%+18.98%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-3.47%-2.86%-18.06%+14.88%-40.43%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
+1.02%-1.09%-22.37%-5.19%+3.52%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-0.59%+17.71%-7.47%+23.58%-22.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
2.17
Hold$530.75-0.34% Downside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.19
Hold$32.4313.19% Upside
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
2.79
Moderate Buy$31.0039.44% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.41
Hold$64.9223.86% Upside

Current Analyst Ratings Breakdown

Latest PRVA, TEM, HIMS, and CHE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $26.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $30.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$21.00 ➝ $28.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$35.00 ➝ $33.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$30.00 ➝ $32.00
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$35.00 ➝ $42.00
8/7/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/7/2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$32.00
8/5/2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/4/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$58.00 ➝ $56.00
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.53B2.75$24.28 per share21.93$63.54 per share8.38
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B2.83$0.80 per share35.81$2.38 per share12.04
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$2.12B1.34$0.28 per share80.71$6.56 per share3.39
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B7.44N/AN/A$2.47 per share21.22
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$265.24M$19.9126.7620.932.0510.60%31.77%18.90%10/27/2026 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.63N/A57.3157.49-5.51%-5.89%-1.39%11/2/2026 (Estimated)
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.92M$0.21105.8854.221.741.19%3.52%2.00%N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%N/A

Latest PRVA, TEM, HIMS, and CHE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.0498-$0.37-$0.3202-$0.37$698.90 million$753.21 million
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
7/28/2026Q2 2026
Chemed Corporation stock logo
CHE
Chemed
$5.60$6.06+$0.46$5.13$665.04 million$673.25 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.400.45%+10.76%12.05%16 Years
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A

Latest PRVA, TEM, HIMS, and CHE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.700.51%8/17/20268/17/20269/3/2026
5/18/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.600.55%5/28/20265/28/20266/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
0.17
0.91
0.89
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.18
1.69
1.56
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
N/A
1.62
1.62
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
94.48%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.33%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
5.70%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.07 million12.64 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442231.46 million204.24 millionOptionable
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
1,226127.73 million120.45 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionN/A

Recent News About These Companies

Dimensional Fund Advisors LP Has $1.85 Million Stock Holdings in Tempus AI, Inc. $TEM
August 14 at 3:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-has-185-million-stock-holdings-in-tempus-ai-inc-tem-2026-08-14/
Tempus AI's FDA Win Could Unlock Major Reimbursement Growth Ahead
August 13 at 10:11 AM  |  zacks.comhttps://www.zacks.com/stock/news/2974115/tempus-ai-s-fda-win-could-unlock-major-reimbursement-growth-ahead?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2974115
Bios Life Emerges from Stealth with $25M and Partners with Tempus to Personalize Cancer Screening and Surveillance
August 13 at 9:48 AM  |  oklahoman.comO
Is Tempus AI Worth Buying as Growth Improves but Valuation Stays High?
August 12 at 11:56 AM  |  zacks.comhttps://www.zacks.com/stock/news/2973581/is-tempus-ai-worth-buying-as-growth-improves-but-valuation-stays-high?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2973581
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock
August 11 at 7:06 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-tempus-ai-nasdaqtem-ceo-sells-100080000-in-stock-2026-08-11/
Tempus Q2 Earnings Call Highlights Data Growth and Pricing Upside
August 11 at 11:36 AM  |  zacks.comhttps://www.zacks.com/stock/news/2972877/tempus-q2-earnings-call-highlights-data-growth-and-pricing-upside?cid=cs-stocknewsapi-ft-analyst_blog_plus|earnings_call_takeaways-2972877
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance
August 11 at 9:27 AM  |  thenextweb.comT
Tempus AI (NASDAQ:TEM) Trading 7.5% Higher - Still a Buy?
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tempus-ai-nasdaqtem-trading-75-higher-still-a-buy-2026-08-10/
Top Artificial Intelligence Stocks To Add to Your Watchlist - August 10th
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/top-artificial-intelligence-stocks-to-add-to-your-watchlist-august-10th-2026-08-10/
Finivi Inc. Sells 24,340 Shares of Tempus AI, Inc. $TEM
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-finivi-inc-sells-24340-shares-of-tempus-ai-inc-tem-2026-08-10/
CellCarta Adds Tempus to CDx Commercialization Lab Network
August 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/cellcarta-adds-tempus-to-cdx-commercialization-lab-network-302844793.html
Tempus AI (NASDAQ:TEM) Director David Epstein Sells 370 Shares of Stock
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tempus-ai-nasdaqtem-director-david-epstein-sells-370-shares-of-stock-2026-08-05/
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 23,818 Shares
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-tempus-ai-nasdaqtem-ceo-sells-23818-shares-2026-08-05/
Medical Facilities (OTCMKTS:MFCSF) and Tempus AI (NASDAQ:TEM) Head to Head Review
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30943055
Stifel Nicolaus Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30941579
BTIG Research Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30941254
HC Wainwright Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price
August 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30941247
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
August 4, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260804131477/en/tempus-study-published-in-nature-medicine-demonstrates-best-in-class-performance-of-prism2-across-diagnostic-and-prognostic-applications/
Tempus AI (NASDAQ:TEM) Price Target Cut to $70.00 by Analysts at BTIG Research
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tempus-ai-nasdaqtem-price-target-cut-to-7000-by-analysts-at-btig-research-2026-08-03/
Tempus AI (NASDAQ:TEM) Given New $56.00 Price Target at HC Wainwright
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tempus-ai-nasdaqtem-given-new-5600-price-target-at-hc-wainwright-2026-08-03/
Tempus AI (NASDAQ:TEM) Price Target Cut to $50.00 by Analysts at Stifel Nicolaus
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tempus-ai-nasdaqtem-price-target-cut-to-5000-by-analysts-at-stifel-nicolaus-2026-08-03/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AirJoule logo over flowing water stream, symbolizing water-from-air technology and clean water production innovation.
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
By Thomas Hughes | July 27, 2026
First Internet Bancorp logo illuminated on a glass panel beside a bank card and smartphone with financial charts.
System Upgrade: First Internet Bancorp Options Surge
By Jeffrey Neal Johnson | August 4, 2026
Illustration of a chip-like structure displaying AMD and Anthropic logos connected by colorful data streams in a server room.
AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
By Jeffrey Neal Johnson | July 23, 2026
AMD and Cerebras logos connected by glowing cables between server hardware racks in a data center.
AMD and Cerebras Create A New Blueprint For Hardware
By Jeffrey Neal Johnson | July 24, 2026
Netflix logo projected in a dim living room with a remote and Netflix mug on the coffee table.
Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
By Chris Markoch | July 18, 2026
Chemed stock logo

Chemed NYSE:CHE

$532.56 -4.61 (-0.86%)
As of 12:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$28.65 -0.12 (-0.40%)
As of 12:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Privia Health Group stock logo

Privia Health Group NASDAQ:PRVA

$22.23 +0.47 (+2.16%)
As of 12:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$52.42 -1.88 (-3.45%)
As of 12:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas